Indication
Nonconvulsive Status Epilepticus
1 clinical trial
2 products
Product
GanaxoloneClinical trial
A Double-Blind Randomized, Placebo Controlled Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status EpilepticusStatus: Completed, Estimated PCD: 2019-09-18
Product
IV Placebo